Moustafa Abdou: Tumor Lysis Syndrome Is a Preventable but Life-Threatening Oncologic Emergency
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
”Tumor Lysis Syndrome (TLS): Preventable, Yet Potentially Fatal
Tumor Lysis Syndrome remains one of the most critical oncologic emergencies in clinical practice. Rapid tumor cell breakdown can lead to severe metabolic disturbances, including hyperkalemia, hyperuricemia, and acute kidney injury, with potentially life-threatening consequences.
Importantly, TLS is no longer confined to high-grade lymphomas and acute leukemias. With the increasing use of targeted therapies, it is now recognized across a broader spectrum of malignancies.
Early risk stratification, close monitoring, and timely intervention, including hydration and appropriate use of agents such as rasburicase, are essential to improving patient outcomes.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 14:43Mary Cushman: Apply to Shape Scientific Publishing as ISTH Associate Editor
-
Sep 29, 2026, 14:32Honoring Women Leaders Advancing Research, Care, and Innovation in Thrombosis and Hemostasis – Seminars in Thrombosis and Hemostasis
-
Sep 29, 2026, 14:20Nathan Connell: Key Takeaways from the 8th Aland Island Meeting on von Willebrand Disease
-
Sep 29, 2026, 14:09Mariusz Ratajczak: Are We Inadvertently Destroying the True Regenerative Power of PRP by Discarding the Plasma?
-
Sep 29, 2026, 14:00Nithin M: Proximal Splenic Artery Embolization Prior to Shunt-Directed Variceal Therapy
-
Sep 29, 2026, 13:12Wolfgang Miesbach: Teclistamab Targets the Source of Pathogenic Autoantibodies
-
Sep 29, 2026, 12:37Dan Milikovsky: Uncovering Cerebrovascular Injury in Sickle Cell Disease
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?